INTRODUCTION
============

Chagas disease (CD) has become a global problem due to changing migration patterns^([@B1],[@B2])^. Approximately 13 million people are affected by CD both in endemic and non-endemic countries^([@B3])^. Approximately 20 to 30% of patients with CD in the so-called indeterminate stage will progress to over cardiomyopathy and develop arrhythmic and/or cardiomyopathic complications, manifested clinically by palpitations, dizziness, syncope, heart failure, and sudden death^([@B4],[@B5])^. Chronic inflammation usually triggered by parasite persistence may lead to fibrosis and result in sinus node dysfunction, atrioventricular and intraventricular conduction abnormalities, and ventricular tachyarrhythmias due to reentry^([@B6],[@B7])^. The adequate assessment of patients with CD involves the use of supplementary methods to investigate atrial and ventricular arrhythmias^([@B5])^. Twelve-lead electrocardiogram (ECG), echocardiogram, and 24-hour Holter monitoring are usually used for risk stratification^([@B8])^. Electrophysiological testing is generally indicated for the assessment of sinus node function, conduction through the atrioventricular node and His-Purkinje system, and evaluation of the mechanisms of arrhythmia.

OBJECTIVE
=========

The aim of this study was to describe the characteristics of the electrophysiological findings in patients with Chagas disease.

METHODS
=======

Study design
------------

This is a retrospective descriptive study that included all consecutive patients with CD undergoing electrophysiological study (EPS) over the last 3 years in a tertiary hospital in Brazil. Indications for EPS included syncope in 52.2% of cases (two patients with documented sustained ventricular tachycardia), and non-sustained ventricular arrhythmias (frequent premature ventricular contractions and/or non-sustained ventricular tachycardia on Holter monitoring), with or without left ventricular systolic dysfunction in 47.8% of cases. Baseline characteristics (age, hyperlipidemia, history of syncope, tobacco use, prior stroke or transient ischemic attack, systemic arterial hypertension, coronary artery disease, *diabetes mellitus, New York Heart Association* - NYHA - functional class, and concomitant medications), electrocardiogram findings (rhythm, presence of atrioventricular or intraventricular blocks), and echocardiogram findings (ejection fraction, left atrium size, diastolic dysfunction, right ventricle dysfunction, left ventricle thrombus, and left ventricle aneurysm), and 24-hour Holter monitoring findings (premature ventricular contractions, and non-sustained or sustained ventricular tachycardia) were obtained through a chart review, recorded on specifically designed case report forms and correlated with the EPS findings.

This study was approved by the Research Ethics Committee of *Instituto Dante Pazzanese de Cardiologia* (protocol number 4,208). A statistician analyzed the data.

Study population
----------------

All patients with at least two positive serologies for *Trypanosoma cruzi* (ELISA, indirect or direct immunofluorescence) who underwent EPS over the last 3 years were included in the study. Patients with cardiomyopathy secondary to other etiologies such as ischemia (severe coronary artery disease or history of myocardial infarction) and hypertension were excluded.

Definitions
-----------

Low QRS voltage was defined by QRS complex amplitude \<0.5mV in frontal leads and \<1.0mV in precordial leads, according to the guidelines of the Brazilian Society of Cardiology and Emission Analysis of Electrocardiographic Reports, in 2009^([@B9])^. Non-sustained ventricular tachycardia was defined as the presence of at least three consecutive ventricular beats at a heart rate of \>100bpm. Sustained ventricular tachycardia was defined as tachycardia originating in the ventricles with a heart rate of at least 100bpm, lasting at least 30 seconds and/or associated with hemodynamic or clinical instability. Diagnosis of coronary artery disease (CAD) was defined by the presence of at least one vessel with stenosis \>50% on angiogram. In cases of symptoms compatible with coronary disease in the absence of risk factors, patients with normal exercise testing, myocardial scintigraphy, or cardiac angiotomography were considered to have no CAD.

Electrophysiological study
--------------------------

Baseline measurements including AH and HV intervals were made for the definition of intranodal and intraventricular conduction abnormalities. Sinus node function was assessed by corrected sinus node recovery time and sinoatrial conduction time measurements, both obtained with rapid atrial stimulation. Right atrium, atrioventricular node, and right ventricular refractory periods were determined using standard programmed stimulation methods.

All patients underwent programmed ventricular stimulation with up to three extra stimuli and rapid ventricular pacing (up to 250ms) in the right ventricular apex and right ventricular outflow tract. Inducible sustained ventricular arrhythmias were defined as sustained ventricular tachycardia or fibrillation on the EPS.

Statistical analysis
--------------------

Continuous variables were described as mean and standard deviation or median and interquartile range, when appropriate. Categorical data were presented as relative and absolute frequencies. The difference between groups regarding inducibility and non-inducibility was analyzed by the t-test or Mann-Whitney test for continuous variables and Fisher\'s exact test or χ^2^ for categorical variables. A logistic regression model was used for measures of association between categories of ejection fraction (\<40%, between 40 and 60%, and\> 60%) and inducibility of ventricular arrhythmias on the EPS. p-values \<0.05 were considered statistically significant.

RESULTS
=======

One hundred and forty-one charts were reviewed. We excluded 26 patients: 5 due to concomitant severe coronary artery disease, 12 due to no available Chagas serology results, and 9 due to incomplete chart information. Therefore, 115 patients were included in the analysis. Mean age was 58.4 years (SD: 10.3), 60 (52.2%) were male, 75 (65.2%) had systemic hypertension, and 104 patients (90.4%) were in either NYHA functional class I or II. Baseline characteristics are described on [table 1](#t1){ref-type="table"}.

###### Baseline characteristics

  Characteristics         n=115         VT/VF                                 
  ----------------------- ------------- ------------- ----------- ----------- --
  Age (y) - Mean (SD)     58.4 (10.3)   59.6 (10.2)   57 (10.5)   0.18        
  Male sex                60 (52.2)     27 (45)       33 (60)     0.10        
  Hyperlipidemia          42 (36.5)     24 (40)       18 (32.7)   0.41        
  History of syncope      60 (52.2)     29 (48.3)     31 (56.4)   0.38        
  Tobacco use             6 (5.2)       4 (6.7)       2 (3.6)     0.68        
  Prior stroke/TIA        9 (7.8)       4 (6.7)       5 (9.1)     0.73        
  Systemic hypertension   75 (65.2)     40 (66.7)     35 (63.6)   0.73        
  Diabetes mellitus       12 (10.4)     9 (15)        3 (5.5)     0.09        
  NYHA functional class                                           0.31        
                          I             56 (48.7)     33 (55)     23 (41.8)   
                          II            2 (1.7)       23 (38.3)   25 (45.3)   
                          III           48 (41.7)     4 (6.7)     5 (9.1)     
                          IV            9 (7.8)       0           2 (3.6)     

VT/VF: ventricular tachycardia/ventricular fibrillation; SD: standard deviation; TIA: transitory ischemic attack; NYHA: New York Heart Association.

More than 50% of patients were on angiotensin converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB), β-blockers, or amiodarone (95, 82.6%; 74, 64.3%; and 71, 61.7%, respectively). Concomitant medications are shown on [table 2](#t2){ref-type="table"}.

###### Concomitant medications

  Medications           n=115 (%)   VT/VF                   
  --------------------- ----------- ----------- ----------- ------
  Beta-blockers         74 (64.3)   32 (53.3)   42 (76.4)   0.01
  Amiodarone            71 (61.7)   34 (56.7)   37 (67.3)   0.24
  ACEI/ARB              95 (82.6)   50 (83.3)   45 (81.8)   0.83
  Furosemide            41 (35.7)   16 (26.7)   25 (45.5)   0.03
  Statin                34 (29.6)   21 (35)     13 (23.6)   0.18
  Aspirin               48 (41.7)   26 (43.3)   22 (40)     0.71
  Oral anticoagulants   11 (9.6)    6 (10)      5 (9.1)     0.86
  Spironolactone        45 (39.1)   17 (28.3)   28 (50.9)   0.01

VT/VF: ventricular tachycardia/ventricular fibrillation; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin II receptor blocker.

Ninety-nine patients (86%) were in sinus rhythm and the most common conduction disturbance was left anterior fascicular block (n=62; 53.9%), followed by right bundle branch block (n=56; 48.7%). The mean ejection fraction (EF) was 45% (SD: 16.2). [Table 3](#t3){ref-type="table"} summarizes the electrocardiographic, echocardiographic, and 24-hour Holter findings.

###### Electrocardiographic, echocardiographic, and 24-hour Holter findings

  Electrocardiogram findings                                                  n=115 (%)    VT/VF                    
  --------------------------------------------------------------------------- ------------ ------------ ----------- --------
  Sinus rhythm                                                                99 (86.1)    52 (86.7)    47 (85.5)   0.85
  Atrial fibrillation                                                         5 (4.3)      4 (6.7)      1 (1.8)     0.36
  Paced rhythm                                                                16 (13.9)    7 (11.7)     9 (16.4)    0.46
  First degree AV block                                                       42 (36.5)    21 (35)      21 (38.2)   0.72
  Right bundle branch block                                                   56 (48.7)    35 (58.3)    21 (38.2)   0.03
  Left anterior hemiblock                                                     62 (53.9)    36 (60)      26 (47.3)   0.17
  Left bundle branch block                                                    17 (14.8)    6 (10)       11 (20)     0.13
  Low QRS voltage                                                             9 (7.8)      5 (8.3)      4 (7.3)     1
  **Echocardiogram findings** [\*](#TFN3){ref-type="table-fn"}                                                      
  Diastolic dysfunction                                                       59 (53.2)    36 (62.1)    23 (43.4)   0.04
  RV dysfunction                                                              5 (4.5)      1 (1.7)      4 (7.5)     0.18
  LV thrombus                                                                 1 (0.9)      0            1 (1.9)     0.47
  LV aneurysm                                                                 6 (5.4)      3 (5.1)      3 (5.7)     1
  EF (%), mean (SD)                                                           45 (16.2)    51 (16.1)    38 (13.6)   \<0.01
  Left atrium (mm), mean (SD) 42.5 (7.6)                                      41.6 (7.8)   43.5 (7.4)   0.03        
  **24-hour Holter monitoring findings** [\*\*](#TFN4){ref-type="table-fn"}                                         
  \>30 PVC/h                                                                  64 (57.1)    32 (55.2)    32 (59.3)   0.66
  NSVT                                                                        66 (58.9)    32 (55.2)    34 (63)     0.40
  Sustained VT                                                                2 (1.8)      1 (1.7)      1 (1.9)     1

Two patients had no echocardiography available in the medical chart, one patient only had the ejection fraction described in the chart, and for one patient it was not possible to assess diastolic function due to E- and A-wave fusion.

three patients had no 24-hour Holter monitoring result.

VT/VF: ventricular tachycardia/ventricular fibrillation; AV: atrioventricular; RV: right ventricle; LV: left ventricle; EF: ejection fraction; SD: standard deviation; PVC: premature ventricular contractions; NSVT: non-sustained ventricular tachycardia; VT: ventricular tachycardia.

Electrophysiological study
--------------------------

The corrected sinus node recovery time and sinoatrial conduction time were abnormal in 8 (6.9%) and 30 (26.1%) patients, respectively. Mean corrected sinus node recovery time was 336.1ms (SD: 171.7) and mean sinoatrial conduction time was 212.8ms (SD: 82.1).

The mean AH and HV intervals were 121.4ms (SD: 56.7) and 59.2ms (SD: 16.8), respectively. Thirty-seven patients (32.2%) had abnormal atrioventricular conduction (prolonged A-H interval). Intraventricular conduction, determined by the HV interval, was abnormal in 39 (33.9%) patients ([Table 4](#t4){ref-type="table"}).

###### Electrophysiological study findings

  Measurement                                                    Mean ms (SD)    Abnormal (% patients)
  -------------------------------------------------------------- --------------- -----------------------
  Corrected sinus node recovery time (normal range: 100-520ms)   336.1 (171.7)   8 (6.9)
  Sinoatrial conduction time (normal range: 120-215ms)           212.8 (82.1)    30 (26.1)
  AH interval (normal range: 55-120ms)                           121.4 (56.7)    37 (32.2)
  HV interval (normal range: 35-55ms)                            59.2 (16.8)     39 (33.9)

SD: standard deviation.

Fifty-five (47.8%) patients had induced sustained ventricular arrhythmias. Most of them were monomorphic (n=46; 83.6%). Right bundle branch block was the most common morphology (n=29; 52.7%). Twenty-eight patients (50.9%) had induced sustained ventricular arrhythmias associated with symptoms or hemodynamic instability. In 51 patients (93%), the mode of reversal was described as follows: 33 (60%) required electrical cardioversion, 15 (27.3%) overdrive suppression, 1 (1.8%) terminated spontaneously, and in 2 (3.6%), the ventricular tachycardia was terminated during radiofrequency ablation. The most common site of origin of ventricular arrhythmias was the left ventricular inferoseptal wall (n=10; 18.2%), followed by the left ventricular posterobasal wall (n=6; 11%). The characteristics of induced sustained ventricular arrhythmias are described on [table 5](#t5){ref-type="table"}.

###### Characteristics of sustained ventricular arrhythmias

  Electrophysiological study findings   n (%)                                 
  ------------------------------------- ------------------------------------- -----------
  VT/VF                                 55 (47.8)                             
                                        Monomorphic ventricular tachycardia   46 (83.6)
                                        Polymorphic ventricular tachycardia   3 (5.4)
                                        Ventricular flutter                   3 (5.4)
                                        Ventricular fibrillation              3 (5.4)
  Reversal of arrhythmias                                                     
                                        Electrical cardioversion              33 (60)
                                        Overdrive                             15 (27.3)
                                        Spontaneous                           1 (1.8)
                                        Radiofrequency                        2 (3.6)
  Morphology                                                                  
                                        Right bundle branch block             29 (52.7)
                                        Left bundle branch block              15 (27.3)
                                        Other                                 11 (20)
  Origin                                                                      
  Left ventricle                                                              
                                        Inferoseptal wall                     10 (18.2)
                                        Posterobasal wall                     6 (11)
                                        Inferoapical wall                     2 (3.6)
                                        Papillary muscle                      2 (3.6)
                                        Inferoposterior wall                  1 (1.8)
                                        Posterolateral wall                   1 (1.8)
                                        Inferior wall                         1 (1.8)
                                        Anterolateral wall                    1 (1.8)
                                        Left medial septum                    1 (1.8)
                                        Anteroapical wall                     1 (1.8)
  Right ventricle                                                             
                                        Right ventricular outflow tract       5 (9.1)
                                        Right medial septum                   4 (7.3)
                                        Inferior/inferoapical                 3 (5.4)
                                        Inferoseptal                          1 (1.8)
                                        Other                                 2 (3.6)

VT: ventricular tachycardia, VF: ventricular fibrillation.

Among patients who developed ventricular tachycardia/ventricular fibrillation (VT/VF) on the EPS, most of them were on beta-blockers and this difference reached statistical significance (76.4% *versus* 53.3%; p=0.01). The mean ejection fraction was lower in the group with inducible VT/VF (38%, SD: 13.6 *versus* 51%, SD: 16.1; p\<0.01). Patients with an EF\<40% had a 1.94-fold increased risk of VT/VF seen on the EPS compared to those with an EF\>60% (OR: 1.94, 95%CI: 1.12-3.38; p=0.01). Moreover, an EF\>60% had a protective effect over the risk of VT/VF (OR: 0.20, 95%CI: 0.08-0.49; p\<0.01). Ejection fractions between 40 and 60% had no effect on the induction of VT/VF (OR: 1.0, 95%CI 0.43-2.30; p=1). The presence of complex ventricular arrhythmias on 24-hour Holter monitoring was not associated with increased risk of inducible ventricular arrhythmias.

DISCUSSION
==========

The main finding of our study was that, similarly to those with both non-ischemic and ischemic dilated cardiomyopathy, patients with *Trypanosoma cruzi* infection with an ejection fraction\<40% had an increased risk of inducible malignant ventricular arrhythmias. On the other hand, despite the high prevalence of frequent premature ventricular contractions, the presence of ventricular arrhythmias on Holter did not predict the inducibility of malignant arrhythmias on EPS. This most likely reflects the diffuse muscular damage in patients with CD.

Takehara et al. demonstrated the left ventricular inferolateral wall to be the most common site of origin of ventricular tachycardia in patients with CD, followed by septal and apical regions^([@B10])^. In our sample, the most common site of origin of ventricular arrhythmias was the left ventricular inferoseptal wall (18.2%), followed by the posterobasal region (11%). This finding reinforces the hypothesis that despite the fact that ventricular apical aneurysms are commonly seen in patients with CD (5.4% of cases in our study), most ventricular arrhythmias are not originated from or around the aneurysm. The predilection for the left ventricular wall, however, is still uncertain.

In general, an EPS is not imperative to reach a therapeutic decision in patients with sinus node disease. Pacemaker implantation is usually recommended in the presence of symptoms secondary to bradyarrhythmias, advanced atrioventricular (AV) block, and chronotropic incompetence. Programmed ventricular stimulation is usually indicated in cases of syncope of uncertain etiology^([@B11])^. Maia et al. and Pimenta et al. reported sinus dysfunction in 30% and 18.1% of cases of patients with chronic Chagas cardiomyopathy, respectively, which is in agreement with our findings (27% of cases)^([@B12],[@B13])^.

Finally, both atrioventricular and intraventricular conduction disturbances are generally seen in clinical practice in Chagas patients. The EPS is usually indicated for patients with intraventricular block and syncope symptoms of unclear etiology^([@B14])^. In our study, atrioventricular node conduction abnormalities were observed in 32% of patients, and His-Purkinje system disease in 33.91%.

Limitations
-----------

Our study has several limitations. The descriptive design, small number of patients, and information obtained based solely on medical charts are the main limitations.

CONCLUSIONS
===========

Chagas patients with low ejection fraction have an increased risk of inducible malignant ventricular arrhythmias. Sinus node dysfunction, atrioventricular node and His-Purkinje conduction abnormalities occur in almost one third of patients. The presence of complex ventricular arrhythmias on 24-hour Holter monitoring was not associated with increased risk of inducible ventricular arrhythmias.

*Study carried out at Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil.*
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